Robert William Georgantas III - 10 Mar 2022 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Chief Scientific Officer
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Robert Georgantas III
Issuer symbol
BDSX
Transactions as of
10 Mar 2022
Net transactions value
$0
Form type
4
Filing time
14 Mar 2022, 17:56:03 UTC
Previous filing
10 Feb 2022
Next filing
11 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Stock Options (Right to buy) Award $0 +22,722 $0.000000 22,722 10 Mar 2022 Common Stock 22,722 $2.29 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.